View Full Text | Abstract |
Article as PDF | Print this Article |
Pubmed | PMC |
PubReader | Export to Citation |
Email Alerts | Open Access |
Exp Neurobiol 2018; 27(4): 309-319
Published online August 30, 2018
https://doi.org/10.5607/en.2018.27.4.309
© The Korean Society for Brain and Neural Sciences
Eugene Bok1, Eun Ju Cho2, Eun Sook Chung2, Won-Ho Shin1*, and Byung Kwan Jin2*
1Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Korea.
2Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Korea.
Correspondence to: *To whom correspondence should be addressed.
Won-Ho Shin, TEL: 82-42-610-8088, FAX: 82-42-610-8157
e-mail: whshin@kitox.re.kr
Byung Kwan Jin, TEL: 82-2-969-4563, FAX: 82-2-969-4570
e-mail: bkjin@khu.ac.kr
The present study investigated the effects of interleukin (IL)-4 on dopamine (DA) neurons in the substantia nigra (SN)
Keywords: Interleukin-4, Parkinson disease, Substantia nigra, Dopaminergic neurons, Lipopolysaccharides